Vetrawin 500 mg

Indications:

Frequent (15%–10%): Drowsiness asthenia headache infection. Occasional (9%–3%): Dizziness pharyngitis pain depression anxiety vertigo rhinitis anorexia. Rare (less than 3%): Amnesia emotional lability cough sinusitis anorexia diplopia. Adverse effects/toxic reactions Acute psychosis agitation delirium impulsivity have been reported. Sudden discontinuance increases risk of seizure activity. Serious dermatological reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported.